Bill

Bill > S1282


MA S1282

MA S1282
Resolve establishing a special commission on psychedelic drug use for clinical trials and therapy


summary

Introduced
03/29/2021
In Committee
03/29/2021
Crossed Over
Passed
Dead
12/31/2022

Introduced Session

192nd General Court

Bill Summary

For legislation to establish a special commission on psychedelic drug use for clinical trials and therapy. Mental Health, Substance Use and Recovery.

AI Summary

This bill establishes a special commission to evaluate and study the costs and benefits of using psychedelic drugs, which are currently being destroyed under existing law, for clinical trials and therapy. The commission will review the benefits of using psychedelic drugs in clinical trials, recommend appropriate regulations, explore the potential for expanding their use from clinical trials to standard therapeutic use, and recommend any changes to existing law regarding psychedelic drugs in Massachusetts. The commission will consist of various state officials and representatives, and it will submit its recommendations, including any proposed legislation, to the legislature by May 1, 2022.

Committee Categories

Health and Social Services

Sponsors (1)

Last Action

Accompanied a study order, see S2919 (on 06/09/2022)

bill text


bill summary

Loading...

bill summary

Loading...

bill summary

Loading...